Coix Seed Oil Exerts an Anti-Triple-Negative Breast Cancer Effect by Disrupting miR-205/S1PR1 Axis
Coix Seed Oil (CSO) possesses a wide range of pharmacological activities. Kanglaite Injection, a commercial product of CSO, has been used clinically as an anticancer drug in China for decades. However, its molecular mechanisms on triple-negative breast cancer (TNBC) remains to be elucidated. In this...
Saved in:
Main Authors: | Ting Fang (Author), Yi-Xin Jiang (Author), Long Chen (Author), Ling Huang (Author), Xin-Hui Tian (Author), Yu-Dong Zhou (Author), Dale G. Nagle (Author), Dan-Dan Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Coix seed oil ameliorates cancer cachexia by counteracting muscle loss and fat lipolysis
by: Huiquan Liu, et al.
Published: (2019) -
Erratum to Czubacka and Czerczak "2-Naphthylamine toxicity" (Med Pr 2020;71(2):205-20)
by: Ewelina Czubacka, et al.
Published: (2021) -
S1P/S1PR1 signaling is involved in the development of nociceptive pain
by: Daosong Dong, et al.
Published: (2024) -
10 PRINT CHR$(205.5+RND(1)); GOTO 10
by: Montfort, Nick
Published: (2014) -
10 PRINT CHR$(205.5+RND(1)); : GOTO 10
by: Montfort, Nick
Published: (2012)